Jonathan Lehman
-
Lung cancer survival signal
New research by Jonathan Lehman and Pierre Massion have identfied a bioimarker that suggests poor prognosis for small-cell lung cancer, as well as potential target for new therapies. Read MoreNov 30, 2018
-
VUMC’s Lehman lands LUNGevity research support
Jonathan Lehman, M.D., Ph.D., instructor in Medicine in the Division of Hematology/Oncology, has received a Career Development Award from LUNGevity, a nonprofit organization that provides support programs for lung cancer patients and families, public education and funding for innovative scientific research. Read MoreSep 22, 2016